Artwork

Content provided by ABG Sundal Collier. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ABG Sundal Collier or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Biovica - Intervju med VD Anders Rylander

3:45
 
Share
 

Archived series ("Inactive feed" status)

When? This feed was archived on August 22, 2019 01:47 (5y ago). Last successful fetch was on February 26, 2019 12:32 (5+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 181021401 series 1019971
Content provided by ABG Sundal Collier. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ABG Sundal Collier or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Biovicas VD Anders Rylander berättar inledningsvis kort om bolaget samt sin egen bakgrund. Därefter svarar han på frågor om hur bolagets produkt DiviTum skiljer sig mot konkurrerande metoder, när bolaget räknar med att produkten skall vara fullt kommersialiserad samt vilka möjligheter som finns att DiviTum även kan fungera på andra cancerformer. Avslutningsvis berättar han vad bolaget har sitt fokus på just nu samt vilka händelser som är av störst intresse för investerare att hålla utkik efter.
  continue reading

250 episodes

Artwork
iconShare
 

Archived series ("Inactive feed" status)

When? This feed was archived on August 22, 2019 01:47 (5y ago). Last successful fetch was on February 26, 2019 12:32 (5+ y ago)

Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 181021401 series 1019971
Content provided by ABG Sundal Collier. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ABG Sundal Collier or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Biovicas VD Anders Rylander berättar inledningsvis kort om bolaget samt sin egen bakgrund. Därefter svarar han på frågor om hur bolagets produkt DiviTum skiljer sig mot konkurrerande metoder, när bolaget räknar med att produkten skall vara fullt kommersialiserad samt vilka möjligheter som finns att DiviTum även kan fungera på andra cancerformer. Avslutningsvis berättar han vad bolaget har sitt fokus på just nu samt vilka händelser som är av störst intresse för investerare att hålla utkik efter.
  continue reading

250 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide